Quanterix (NASDAQ:QTRX) issued its earnings results on Wednesday. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.04), reports.
Shares of Quanterix (NASDAQ QTRX) traded down $0.19 on Wednesday, hitting $20.63. The stock had a trading volume of 194,879 shares, compared to its average volume of 118,886. Quanterix has a 12-month low of $15.56 and a 12-month high of $24.81.
Several research analysts have commented on QTRX shares. JPMorgan Chase & Co. started coverage on Quanterix in a research note on Tuesday, January 2nd. They issued an “overweight” rating for the company. Cowen started coverage on Quanterix in a research note on Tuesday, January 2nd. They issued an “outperform” rating for the company. BTIG Research initiated coverage on Quanterix in a research note on Tuesday, January 2nd. They issued a “buy” rating and a $26.00 target price for the company. Finally, Leerink Swann initiated coverage on Quanterix in a research report on Tuesday, January 2nd. They set an “outperform” rating and a $27.00 price target for the company.
Quanterix Company Profile
Quanterix Corporation is a United States-based company, which develops tools for high definition diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology.
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.